Companies: 10,795·Total market cap: $144.5T
Curaleaf Holdings, Inc.

Curaleaf Holdings, Inc.

CURA.TOTSXHealthcare● Active
$16.21
+$1.00(+6.57%)
Market Cap$3.8B
P/E Ratio
52W High$16.92
52W Low$0.99

Curaleaf Holdings, Inc. (CURA.TO) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CURA.TO · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$101.4M +9.0% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$101.4M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+9.0%
vs prior fiscal year
Latest Quarter
$106.2M
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$101.4MCash on Hand
Total Debt$1.04BTotal Debt
Net Cash / Net Debt−$933.8MNet Debt Position
Cash vs Debt Ratio
Cash 9%Debt 91%

Curaleaf Holdings, Inc. carries a net debt position of $933.8M. Total debt ($1.04B) exceeds cash on hand ($101.4M). Curaleaf Holdings, Inc. cash vs debt ratio: 9% cash / 91% debt.

Net Cash = Cash & ST Investments − Total Debt$101.4M$1.04B = −$933.8M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
CURA.TO annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$101.4M+9.0%
Dec 31, 2024$93.0M+1.3%
Dec 31, 2023$91.8M-43.7%
Dec 31, 2022$163.2M-45.5%
Dec 31, 2021$299.3M+307.0%
CURA.TO cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc.YOU
CURA.TO
$101.4M2.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Curaleaf Holdings, Inc. (CURA.TO) cash on hand as of December 31, 2025 is $101.4M, comprising $101.4M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Curaleaf Holdings, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Curaleaf Holdings, Inc. cash reserves or cash position.

Curaleaf Holdings, Inc. annual cash on hand history shows increased +9.0% in 2025: increased +9.0% in 2025. Curaleaf Holdings, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Curaleaf Holdings, Inc. carries total debt of $1.04B against cash of $101.4M, resulting in a net debt position of -$933.8M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

CURA.TO cash on hand · 5 questions

As of December 31, 2025, Curaleaf Holdings, Inc. (CURA.TO) has $101,388,151 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $101,388,151 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $106,204,036. Data sourced from the annual 10-K filing via FMP.

CURA.TO cash on handCURA.TO cash reservesCURA.TO cash 2025how much cash does CURA.TO have

Source: FMP /balance-sheet-statement · US GAAP · Curaleaf Holdings, Inc. · Curaleaf Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025